LIC MF Healthcare Fund Regular-IDCW Reinvestment
LIC MF Healthcare Fund Regular-IDCW Reinvestment: Mutual Fund Overview
LIC MF Healthcare Fund Regular-IDCW Reinvestment is an Sectoral-Pharma mutual fund with over 7.03 years of performance history. The scheme manages an AUM of ₹82.13 Cr and has a NAV of ₹28.6939. It is rated '1' stars by analysts. Investors can begin a SIP with as little as ₹200.0, making it accessible for all types of investors. In the last 1 year, the fund has delivered a return of 6.94%.
Equity, Sectoral-Pharma, Principal at very high risk
1 Year Return 6.94% at 12 Mar 2026 08:59 PM
Fund Details
NAV 28.6939
Sub-Type Sectoral-Pharma
Rating 1
Min. SIP Amount ₹200.0
Fund Age(Year) 7.03
Fund Size(in Crores) 82.13
Fund Performance
1 Month 1.38%
3 Month -1.83%
6 Month -3.37%
1 Year 6.94%
3 Year 22.53%
5 Year 11.98%
Know This Fund
As on 12 Mar 2026
Investment strategy that balances risk & reward by dividing the investment portfolio among different types of asset classes.
Equity (96.23%) Market Cap Small Cap 34.22 Mid Cap 29.11 Large Cap 32.91 Top Sectors Healthcare 91.53 Chemicals 4.7 Top Holding Torrent Pharmaceuticals 6.93 Piramal Pharma 4.3 Concord Biotech 3.05 Dr. Agarwal's Health Care 2.18 Max Healthcare Institute 2.23 Aurobindo Pharma 4.65 Abbott India 3.13 Neuland Laboratories 4.04 Anthem Biosciences 2.16 Navin Fluorine International 3.14 Onesource Specialty Pharma 3.63 Ipca Laboratories 3.09 Mankind Pharma 2.35 Artemis Medicare Services 2.73 Gland Pharma 3.12 Fortis Healthcare 4.94 Glenmark Pharmaceuticals 3.12 Divi's Laboratories 4.81 Acutaas Chemicals 1.65 Vinati Organics 1.57 Alkem Laboratories 3.44 Apollo Hospitals Enterprise 6.87 Sun Pharmaceutical Industries 11.09 Metropolis Healthcare 2.74 Global Health 2.07 Cipla 3.21
Debt & Others (3.77%) Sector Allocation Repo 3.9 Net Payables -0.13 Debt Credit Ratings Debt Category Others 3.77
Comparison with same funds
Equity, Flexi Cap funds Aditya Birla Sun Life Pharma & Healthcare Fund Regular-Growth Ret 1M 1.98% Ret 1Y 11.98% Ret 3Y 24.68% Ret 5Y 14.39%
Equity, Flexi Cap funds Aditya Birla Sun Life Pharma & Healthcare Fund Regular-IDCW Ret 1M 1.98% Ret 1Y 11.98% Ret 3Y 24.68% Ret 5Y 14.39%
Equity, Flexi Cap funds Aditya Birla Sun Life Pharma & Healthcare Fund Regular-IDCW Reinvestment Ret 1M 1.98% Ret 1Y 11.98% Ret 3Y 24.68% Ret 5Y 14.39%
Equity, Flexi Cap funds Bajaj Finserv Healthcare Fund Regular-Growth Ret 1M -0.57% Ret 1Y 8.51% Ret 3Y 0% Ret 5Y 0%
Equity, Flexi Cap funds Bajaj Finserv Healthcare Fund Regular-IDCW Payout Ret 1M -0.57% Ret 1Y 8.51% Ret 3Y 0% Ret 5Y 0%
Equity, Flexi Cap funds Bajaj Finserv Healthcare Fund Regular-IDCW Reinvestment Ret 1M -0.57% Ret 1Y 8.51% Ret 3Y 0% Ret 5Y 0%
Equity, Flexi Cap funds Bandhan BSE Healthcare Index Fund Regular-Growth Ret 1M 1.7% Ret 1Y 11.07% Ret 3Y 0% Ret 5Y 0%
Equity, Flexi Cap funds Bandhan Healthcare Fund Regular - Growth Ret 1M 1.28% Ret 1Y 0% Ret 3Y 0% Ret 5Y 0%
Equity, Flexi Cap funds Bandhan Healthcare Fund Regular - IDCW Ret 1M 1.28% Ret 1Y 0% Ret 3Y 0% Ret 5Y 0%
Equity, Flexi Cap funds Bandhan Healthcare Fund Regular - IDCW Reinvestment Ret 1M 1.28% Ret 1Y 0% Ret 3Y 0% Ret 5Y 0%
Equity, Flexi Cap funds Baroda BNP Paribas Health and Wellness Fund Regular-Growth Ret 1M 1.41% Ret 1Y 0% Ret 3Y 0% Ret 5Y 0%
Charges & Taxes Expense Ratio
Returns are taxed as per your Income Tax Slab.
Expense Ratio (Inclusive of GST): 2.36%
Exit Load 1.0%
Stamp Duty 0.005%
Fund Management
The various expenses, charges and taxes associated with your Mutual Fund
Karan Doshi
Education Mr. Doshi is a Bachelor of Engineering, MMS (Finance)
Experience Prior to joining LIC Mutual Fund, he has worked with Subhkam Ventures Pvt. Limited as Equity Analyst.
Riskometer
Mutual Fund Investments are subject to market risk. Read all scheme related documents carefully.
Principal at very high risk
AMC and Fund details
Rank (total sets) 24
Date of Incorporation 2019-02-28
Total AUM 47476.47
The Scheme Seeks to generate returns from a portfolio of pure debt oriented funds accessed through the diverse investment styles of underlying schemes selected in accordance with the BSLAMC process.